Prelude Therapeutics (PRLD)
0.67
-0.04 (-5.38%)
At close: Apr 04, 2025, 1:54 PM
Prelude Therapeutics Revenue
Prelude Therapeutics reported an annual revenue of $7M, reflecting a 0% growth. For the quarter ending December 31, 2024, Prelude Therapeutics generated $4M in revenue.
Revenue (ttm)
$7M
Revenue Growth
0%
Price / Sales Ratio
13.75
Revenue / Employee
$53.44K
Employees
131
Market Cap
36.83M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 7M | +Infinity% |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |